> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# ICON Will Report Third Quarter Results After The Close On October 27, Call Set For 8:00am ET Next Day
- URL: https://www.bullished.co/icon-will-report-third-quarter-results-after-the-close-on-october-27-call-set-for-8-00am-2a5486ab/
- Published: 2026-10-08T12:21:30.000Z
- Updated: 2026-10-08T12:21:30.000Z
- Description: The clinical research company will hold a webcast on October 28, with a replay posted about an hour after the call ends.
- Author: Matteo Parrino
- Tags: Earnings, ICLR, Industry: Healthcare

ICON plc will release its third quarter 2026 results after the market closes on [Tuesday, October 27](https://www.sec.gov/Archives/edgar/data/1060955/000162828026065404/a20261008pressrelease-icon.htm?ref=bullished.co), the company said in a release dated Thursday and furnished to the SEC on Form 6-K. A conference call and webcast follow on Wednesday, October 28, at 8:00am ET.

## What the release says

The Dublin-based clinical research organization, listed on Nasdaq as ICLR, said it will discuss its financial results and performance on the call. The release gives no financial figures and no guidance.

If the schedule changes, the company said it will post updates, along with links to the live webcasts where available, under "Events" in the Investor section of its website.

A replay of the call will be available about one hour after it ends, according to the release.

## Company profile and share data

In its boilerplate, ICON said it employed approximately [40,200 people](https://www.sec.gov/Archives/edgar/data/1060955/000162828026065404/a20261008pressrelease-icon.htm?ref=bullished.co) in 99 locations in 55 countries as at June 30, 2026\. It describes itself as a world-leading clinical research organization serving pharmaceutical, biotechnology, medical device, government and public health clients.

Market data shows a market value of $12.7 billion. The U.S.-listed shares closed at $164.08 at Wednesday's close.

## What to watch

The release carries the usual forward-looking-statement warning. It lists risks including dependence on the pharmaceutical industry and certain clients, competition and consolidation in the industry, exchange rate swings, inflation and rising labor costs. It points readers to the risk factors in the company's annual report on Form 20-F for the year ended December 31, 2025.

Investor relations contact is Kate Haven, Vice President Investor Relations.

The results land after the close on Tuesday, October 27, and the call begins at 8:00am ET on Wednesday, October 28.

### Sources

- [Form 6-K — ICON Schedules Third Quarter 2026 Earnings Conference Call](https://www.sec.gov/Archives/edgar/data/1060955/000162828026065404/a20261008pressrelease-icon.htm?ref=bullished.co) — SEC EDGAR